Loading...
Header Logo
Keywords
Last Name
Institution

KEVIN FISHER

TitleAssistant Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Pathology & Immunology
DivisionPathology
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Gruner SE, Sayeed H, Suarez-Ferguson L, Perez C, Rouce R, Fisher KE, Rau RE. Ponatinib use in two pediatric patients with relapsed Ph?+?ALL with ABL1 kinase domain mutations. Pediatr Hematol Oncol. 2019 Sep 11; 1-6. PMID: 31510844.
      View in: PubMed
    2. Hashmi SK, Punia JN, Marcogliese AN, Gaikwad AS, Fisher KE, Roy A, Rao P, Lopez-Terrada DH, Ringrose J, Loh ML, Niemeyer CM, Rau RE. Sustained remission with azacitidine monotherapy and an aberrant precursor B-lymphoblast population in juvenile myelomonocytic leukemia. Pediatr Blood Cancer. 2019 Oct; 66(10):e27905. PMID: 31250550.
      View in: PubMed
    3. Fisher SB, Cote GJ, Bui-Griffith JH, Lu W, Tang X, Hai T, Fisher KE, Williams MD, Wistuba II, Waguespack SG, Dorman CM, Ludwig MS, Graham PH, Perrier ND, Lee JE, Grubbs EG. Genetic characterization of medullary thyroid cancer in childhood survivors of the Chernobyl accident. Surgery. 2019 Jan; 165(1):58-63. PMID: 30392857.
      View in: PubMed
    4. David MP, Venkatramani R, Lopez-Terrada DH, Roy A, Patil N, Fisher KE. Multimodal molecular analysis of an atypical small cell carcinoma of the ovary, hypercalcemic type. Cold Spring Harb Mol Case Stud. 2018 10; 4(5). PMID: 30275002.
      View in: PubMed
    5. Huho AN, Issaq N, Iacobas I, Elghetany TM, López-Terrada D, Fisher KE, Punia JN. A Rare Case of Pediatric Chronic Myelogenous Leukemia Presenting With Severe Thrombocytosis Without Leukocytosis. Pediatr Dev Pathol. 2018 Jan-Feb; 21(1):100-104. PMID: 29187020.
      View in: PubMed
    6. Fisher KE, Hsu AP, Williams CL, Sayeed H, Merritt BY, Elghetany MT, Holland SM, Bertuch AA, Gramatges MM. Somatic mutations in children with GATA2-associated myelodysplastic syndrome who lack other features of GATA2 deficiency. Blood Adv. 2017 Feb 28; 1(7):443-448. PMID: 29296959.
      View in: PubMed
    7. Ballester LY, Cantu MD, Lim KPH, Sarabia SF, Ferguson LS, Renee Webb C, Allen CE, McClain KL, Mohila CA, Punia JN, Roy A, López-Terrada DH, John Hicks M, Fisher KE. The use of BRAF V600E mutation-specific immunohistochemistry in pediatric Langerhans cell histiocytosis. Hematol Oncol. 2018 Feb; 36(1):307-315. PMID: 28219109.
      View in: PubMed
    8. Huho AN, Issaq N, Iacobas I, Elghetany MT, Lopez-Terrada D, Fisher K, Punia JN. A Rare Case of Pediatric Chronic Myelogenous Leukemia Presenting with Severe Thrombocytosis without Leukocytosis. Pediatr Dev Pathol. 2016 Jul 25. PMID: 27454200.
      View in: PubMed
    9. Hanley KZ, Fadare O, Fisher KE, Atkins KA, Mosunjac MB. Clinical Significance of Positive Pelvic Washings in Uterine Papillary Serous Carcinoma Confined to an Endometrial Polyp. Int J Gynecol Pathol. 2016 May; 35(3):249-55. PMID: 26535985.
      View in: PubMed
    10. Fisher KE, Zhang L, Wang J, Smith GH, Newman S, Schneider TM, Pillai RN, Kudchadkar RR, Owonikoko TK, Ramalingam SS, Lawson DH, Delman KA, El-Rayes BF, Wilson MM, Sullivan HC, Morrison AS, Balci S, Adsay NV, Gal AA, Sica GL, Saxe DF, Mann KP, Hill CE, Khuri FR, Rossi MR. Clinical Validation and Implementation of a Targeted Next-Generation Sequencing Assay to Detect Somatic Variants in Non-Small Cell Lung, Melanoma, and Gastrointestinal Malignancies. J Mol Diagn. 2016 Mar; 18(2):299-315. PMID: 26801070.
      View in: PubMed
    11. Maier CL, Fisher KE, Jones HH, Hill CE, Mann KP, Zhang L. Development and validation of CALR mutation testing for clinical diagnosis. Am J Clin Pathol. 2015 Nov; 144(5):738-45. PMID: 26486738.
      View in: PubMed
    12. Kang HB, Fan J, Lin R, Elf S, Ji Q, Zhao L, Jin L, Seo JH, Shan C, Arbiser JL, Cohen C, Brat D, Miziorko HM, Kim E, Abdel-Wahab O, Merghoub T, Fröhling S, Scholl C, Tamayo P, Barbie DA, Zhou L, Pollack BP, Fisher K, Kudchadkar RR, Lawson DH, Sica G, Rossi M, Lonial S, Khoury HJ, Khuri FR, Lee BH, Boggon TJ, He C, Kang S, Chen J. Metabolic Rewiring by Oncogenic BRAF V600E Links Ketogenesis Pathway to BRAF-MEK1 Signaling. Mol Cell. 2015 Aug 06; 59(3):345-358. PMID: 26145173.
      View in: PubMed
    13. Fisher KE, Cohen C, Palma JF, Longshore JW. BRAF p.V600E immunohistochemistry in challenging samples: about false-positive and false-negative results--reply. Hum Pathol. 2015 Jul; 46(7):1065-6. PMID: 25971545.
      View in: PubMed
    14. Sullivan HC, Fisher KE, Hoffa AL, Wang J, Saxe D, Siddiqui MT, Cohen C. The role of immunohistochemical analysis in the evaluation of EML4-ALK gene rearrangement in lung cancer. Appl Immunohistochem Mol Morphol. 2015 Apr; 23(4):239-44. PMID: 25265433.
      View in: PubMed
    15. Ehsani L, Cohen C, Fisher KE, Siddiqui MT. BRAF mutations in metastatic malignant melanoma: comparison of molecular analysis and immunohistochemical expression. Appl Immunohistochem Mol Morphol. 2014 Oct; 22(9):648-51. PMID: 25046227.
      View in: PubMed
    16. Fisher KE, Neill SG, Ehsani L, Caltharp SA, Siddiqui MT, Cohen C. Immunohistochemical Investigation of BRAF p.V600E mutations in thyroid carcinoma using 2 separate BRAF antibodies. Appl Immunohistochem Mol Morphol. 2014 Sep; 22(8):562-7. PMID: 24897065.
      View in: PubMed
    17. Fisher KE, Smith GH, Neill SG, Rossi MR. Section I: integrating laboratory medicine with tissue specimens. Curr Probl Cancer. 2014 Sep-Oct; 38(5):144-58. PMID: 25239562.
      View in: PubMed
    18. Fisher KE, Neill SG, Smith GH, Pillai RN, Kudchadkar RR, Zhang L, Rossi MR. Introduction: molecular genomics of cancer: linking diagnostic testing and clinical therapy. Curr Probl Cancer. 2014 Sep-Oct; 38(5):142-3. PMID: 25220586.
      View in: PubMed
    19. Zhang L, Rossi MR, Fisher KE. Section II: hematolymphoid malignancies. Curr Probl Cancer. 2014 Sep-Oct; 38(5):159-74. PMID: 25239561.
      View in: PubMed
    20. Fisher KE, Pillai RN, Kudchadkar RR, Rossi MR. Section IV: non-small cell lung cancer and malignant melanoma. Curr Probl Cancer. 2014 Sep-Oct; 38(5):180-98. PMID: 25281457.
      View in: PubMed
    21. Fisher KE, Cohen C, Siddiqui MT, Palma JF, Lipford EH, Longshore JW. Accurate detection of BRAF p.V600E mutations in challenging melanoma specimens requires stringent immunohistochemistry scoring criteria or sensitive molecular assays. Hum Pathol. 2014 Nov; 45(11):2281-93. PMID: 25228337.
      View in: PubMed
    22. Fisher SB, Fisher KE, Squires MH, Patel SH, Kooby DA, El-Rayes BF, Cardona K, Russell MC, Staley CA, Farris AB, Maithel SK. HER2 in resected gastric cancer: Is there prognostic value? J Surg Oncol. 2014 Feb; 109(2):61-6. PMID: 24122802.
      View in: PubMed
    23. Fisher SB, Baxter KJ, Staley CA, Fisher KE, Monson DK, Murray DR, Oskouei SV, Weiss SW, Kooby DA, Maithel SK, Delman KA. The General Surgeon's quandary: atypical lipomatous tumor vs lipoma, who needs a surgical oncologist? J Am Coll Surg. 2013 Nov; 217(5):881-8. PMID: 24074812.
      View in: PubMed
    24. Fisher KE, Yin-Goen Q, Alexis D, Sirintrapun JS, Harrison W, Benjamin Isett R, Rossi MR, Moreno CS, Young AN, Osunkoya AO. Gene expression profiling of clear cell papillary renal cell carcinoma: comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma. Mod Pathol. 2014 Feb; 27(2):222-30. PMID: 23887297.
      View in: PubMed
    25. Squires MH, Fisher SB, Fisher KE, Patel SH, Kooby DA, El-Rayes BF, Staley CA, Farris AB, Maithel SK. Differential expression and prognostic value of ERCC1 and thymidylate synthase in resected gastric adenocarcinoma. Cancer. 2013 Sep 01; 119(17):3242-50. PMID: 23719746.
      View in: PubMed
    26. Fisher KE, Jani JC, Fisher SB, Foulks C, Hill CE, Weber CJ, Cohen C, Sharma J. Epidermal growth factor receptor overexpression is a marker for adverse pathologic features in papillary thyroid carcinoma. J Surg Res. 2013 Nov; 185(1):217-24. PMID: 23746767.
      View in: PubMed
    27. Fisher SB, Fisher KE, Maithel SK. Molecular targeted therapy for biliary tract malignancy: defining the target. Hepatobiliary Surg Nutr. 2012 Dec; 1(1):53-4. PMID: 24570902.
      View in: PubMed
    28. Fisher SB, Fisher KE, Patel SH, Lim MG, Kooby DA, El-Rayes BF, Staley CA, Adsay NV, Farris AB, Maithel SK. Excision repair cross-complementing gene-1, ribonucleotide reductase subunit M1, ribonucleotide reductase subunit M2, and human equilibrative nucleoside transporter-1 expression and prognostic value in biliary tract malignancy. Cancer. 2013 Jan 15; 119(2):454-62. PMID: 22760605.
      View in: PubMed
    29. Fisher KE, Pop A, Koh W, Anthis NJ, Saunders WB, Davis GE. Tumor cell invasion of collagen matrices requires coordinate lipid agonist-induced G-protein and membrane-type matrix metalloproteinase-1-dependent signaling. Mol Cancer. 2006 Dec 08; 5:69. PMID: 17156449.
      View in: PubMed
    FISHER's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description